| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 87.6 | 81.4 | 72.6 |
| Other income | 1.1 | 0.8 | 0.9 |
| Total income | 88.7 | 82.2 | 73.5 |
| Profit before exceptional items & tax | 16.5 | 10.0 | 12.5 |
| Profit before tax | 16.5 | 10.0 | 12.5 |
| Net profit | 12.8 | 6.2 | 9.2 |
| Operating margin | 18.6% | 12.2% | 17.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +39.10% |
|---|---|
| Net profit, quarter on quarter | +106.50% |
| Revenue, year on year | +20.70% |
| Operating profit, year on year | +32.80% |
| Operating profit, quarter on quarter | +67.40% |
BSE results filing, NSE: SURAKSHA. Figures extracted from the filing.
Suraksha Diagnostic Ltd: key numbers
- Share price
- ₹343.30
- Market cap
- ₹1,788 Cr
- Revenue (annual)
- ₹310.4 Cr
- Net profit (annual)
- ₹32.19 Cr
- P/E (TTM)
- 50.0×Sector 57.8×
- Promoter holding
- 49.10%+0.00% QoQ
- FII holding
- 13.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Suraksha Diagnostic Ltd
All →Suraksha Diagnostic Annual General Meeting
Suraksha Diagnostic Ltd held its 21st AGM on September 22, 2026. Members adopted financial statements, approved a final dividend, and ratified cost auditor remuneration.
Suraksha Diagnostic Earnings Call Transcript: Key Takeaways
Suraksha Diagnostic reported a robust Q1 FY27 with 21% revenue growth and 40% PAT growth, driven by expansion in West Bengal and Jharkhand and a high-growth genomics segment.
- Call
- Guides 15% growth
Suraksha Diagnostic Investor Presentation: Key Takeaways
Suraksha Diagnostic reported strong Q1 FY27 results with 21% YoY revenue growth and 14.7% PAT margin. Management is aggressively expanding the hub-and-spoke network beyond West Bengal into Jharkhand and Tripura.
Suraksha Diagnostic Earnings Call: Key Takeaways
Suraksha Diagnostic Limited concluded FY26 with 23.1% revenue growth to INR 3104M. Strategy shifts towards specialized genomics and multi-state expansion into Bihar, Tripura, and Jharkhand.
Suraksha Diagnostic Earnings Call: Key Takeaways
Suraksha Diagnostic reported robust FY26 revenue growth of 23.1% YoY, driven by aggressive regional expansion and a shift toward high-value genomic and specialized radiology testing.
Suraksha Diagnostic Earnings Call: Key Takeaways
Suraksha Diagnostic reported robust FY26 results with 23% revenue growth and 16% EBITDA growth, driven by core diagnostic momentum and expansion in Eastern India.